Moderna in $35 million licensing deal with CytomX
Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.
Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.
The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to a statement.
US scientists have developed a low-cost way to harvest waste energy from visible light communication by using the human body as an antenna.
Dabur India, an ayurvedic and natural healthcare company, forecasts a low to mid-single-digit revenue growth for the third quarter ending December 31 due
Global cold spells and frost days are set to fall as New Year temperatures soar above 20 degrees Celsius in European nations, according
Investigators from India's Director General of Trade Remedies have started an anti-dumping probe into vitamin A palmitate imports from China, the EU and
Constant checking of social media posts response affects neural development in teens
More than 700,000 nurses in the UK's National Health Service (NHS) will go on strike this month following a dispute with the government over salaries.
Spain passes plastic waste decree that will force tobacco companies to clean up cigarette butts from public spaces
There is a predominance of Omicron BA. 5.2 and BF.7 Covid-19 lineages, accounting for 97.5% of all local infections in China, according to